. Bibliographie,

, Article -Bulletin épidémiologique hebdomadaire

D. Sur,

D. Ems, P. Racsa, C. Anderson, F. Gregory, K. Worley et al., Does Hepatitis C Treatment Adherence Affect Risk of Liver Transplantation? A Historical Cohort Study, J Manag Care Spec Pharm. juill, vol.22, issue.7, pp.863-71, 2016.

N. Alkhouri, E. Lawitz, and F. Poordad, Novel treatments for chronic hepatitis C: closing the remaining gaps, Curr Opin Pharmacol, vol.37, pp.107-118, 2017.

P. Stéphanie, L'observance thérapeutique des patients adultes suivis pour des pathologies chroniques en dispensaire à Mayotte : Etude prospective transversale entre juin et novembre, p.59, 2013.

M. Baudrant-boga, Penser autrement le comportement d'adhésion du patient au traitement médicamenteux : modélisation d'une intervention éducative ciblant le patient et ses médicaments dans le but de développer des compétences mobilisables au quotidien -Application aux patients diabétiques de type 2

, Sabaté et World Health Organization -2003 -Adherence to long-term therapies evidence for act

P. T. Donnan, T. M. Macdonald, and A. D. Morris, Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study, Diabet Med J Br Diabet Assoc. avr, vol.19, issue.4, pp.279-84, 2002.

C. Bourgault, M. Sénécal, M. Brisson, M. A. Marentette, and J. Grégoire, Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study, J Hum Hypertens. août, vol.19, issue.8, pp.607-620, 2005.

P. Kothawala, E. Badamgarav, S. Ryu, R. M. Miller, and R. J. Halbert, Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for Osteoporosis, Mayo Clin Proc. 1 déc, vol.82, issue.12, pp.1493-501, 2007.

S. J. Rolnick, P. A. Pawloski, B. D. Hedblom, S. E. Asche, and R. J. Bruzek, Patient characteristics associated with medication adherence, Clin Med Res. juin, vol.11, issue.2, pp.54-65, 2013.

D. Y. Ishisaka, T. Jukes, R. J. Romanelli, K. S. Wong, and T. A. Schiro, Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network, J Am Soc Hypertens JASH. juin, vol.6, issue.3, pp.201-210, 2012.

J. S. Gonzalez, A. W. Batchelder, C. Psaros, and S. A. Safren, Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis, AIDS Treatment, vol.48

, Nonadherence: A Review and Meta-analysis, J Acquir Immune Defic Syndr, vol.58, issue.2, pp.181-188, 1999.

M. R. Dimatteo, H. S. Lepper, and T. W. Croghan, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence, Arch Intern Med. 24 juill, vol.160, issue.14, pp.2101-2108, 2000.

M. Cator, P. Brassard, S. Ducic, and K. Culman,

, Can J Public Health Rev Can Sante Publique. avr, vol.93, issue.2, pp.92-99, 2002.

A. Trindade, A. Ehrlich, A. Kornbluth, and T. Ullman, Are Your Patients Taking Their Medicine? Validation of a New Adherence Scale in Patients with Inflammatory Bowel Disease and Comparison with Physician Perception of Adherence, Inflamm Bowel Dis. 1 févr, vol.17, pp.599-604, 2011.

M. Krousel-wood, T. Islam, L. S. Webber, R. Re, D. E. Morisky et al., New medication adherence scale versus pharmacy fill rates in hypertensive seniors, Am J Manag Care. janv, vol.15, issue.1, pp.59-66, 2009.

D. T. Lau and D. P. Nau, Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes, Diabetes Care. sept, vol.27, issue.9, pp.2149-53, 2004.

J. F. Steiner and A. V. Prochazka, The assessment of refill compliance using pharmacy records: Methods, validity, and applications, J Clin Epidemiol. 1 janv, vol.50, issue.1, pp.105-121, 1997.

N. M. Vink, O. H. Klungel, R. P. Stolk, and P. Denig, Comparison of various measures for assessing medication refill adherence using prescription data, Pharmacoepidemiol Drug Saf. 1 févr, vol.18, issue.2, pp.159-65, 2009.

, Article -Bulletin épidémiologique hebdomadaire

D. Sur,

Z. M. Younossi, M. Stepanova, L. Henry, F. Nader, Y. Younossi et al., Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens, Medicine (Baltimore). juill, vol.95, issue.28, p.4151, 2016.

M. C. Marshall and J. L. Herrera, Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C, Dig Dis Sci, vol.20, 2018.

D. Sur,

, Adherence to Pangenotypic Glecaprevir/Pibrentasvir Treatment and SVR12 in HCVinfected Patients: An Integrated Analysis of the Phase 2/3 Clinical Trial Program, p.23

A. Lehmann, M. Baudrant-boga, B. Allenet, and J. Calop, Optimisation de la dispensation des médicaments hospitaliers aux patients ambulatoires Première partie : conception d'un outil d'information destiné au patient, vol.27, p.11, 2008.

H. Elkout, P. J. Helms, C. R. Simpson, and J. S. Mclay, Adequate Levels of Adherence with Controller Medication Is Associated with Increased Use of Rescue Medication in Asthmatic Children, PLOS ONE. 27 juin, vol.7, issue.6, p.39130, 2012.

G. R. Foster, N. Afdhal, S. K. Roberts, N. Bräu, E. J. Gane et al., Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection, N Engl J Med. 31 déc, vol.373, issue.27, pp.2608-2625, 2015.

C. Hezode, N. Reau, E. S. Svarovskaia, B. P. Doehle, R. Shanmugam et al., Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies, J Hepatol. mai, vol.68, issue.5, pp.895-903, 2018.

, Adhésion des patients porteurs chroniques de l'hépatite B au traitement par nalaogues nucléosidiques ou nucléotidiques en situation de soins courants en région

S. L. Keast, B. Holderread, T. Cothran, and G. H. Skrepnek, Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost, J Am Pharm Assoc JAPhA. 19 juill, 2018.